AGER and amyloidosis: Modulators of RAGE have been studied in regards to several chronic states such as diabetes, cancer, amyloidosis, neurodegenerative diseases such as Alzheimer’s type dementia and even aging.[16, 20, 132, 133] The decoy receptor abilities of sRAGE have been studied extensively in many of these conditions.